CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

by NASDAQ Market News September 3, 2019

NASDAQ Market News
Click here to email author

PDS Biotechnology to Present at the 21st Annual H.C. Wainwright Global Investment Conference

Forty Seven, Inc. Granted Fast Track Designation for Magrolimab (5F9) for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia

Ads